Skip to main content
Year archive

KPM TECH CO., LTD. — 2021 filings

All 22 regulatory filings released by KPM TECH CO., LTD. (042040) in 2021, sourced directly from the official regulator.

22 Filings
2021 Period
2021 filings (22)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
AGM Information
2021-12-15 Korean
분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2021-11-12 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2021-10-29 Korean
전환청구권행사
Share Issue/Capital Change
2021-08-25 Korean
반기보고서 (2021.06)
Interim / Quarterly Report H1 2021
2021-08-13 Korean
[기재정정]투자판단관련주요경영사항(COVID-19 치료제 Lenzilumab의 식약처 가교임상시험 계획 (IND) 승인 신청)
Legal Proceedings Report
2021-07-22 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Q1 2021
2021-05-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2021-04-02 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-03-31 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2021-03-29 Korean
감사보고서제출
Audit Report / Information FY 2020
2021-03-19 Korean
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-19 Korean
사업보고서 (2020.12)
Annual Report FY 2020
2021-03-19 Korean
주주총회소집결의
AGM Information
2021-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2020
2021-03-02 Korean
주주총회소집공고
AGM Information
2021-03-02 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2021-03-02 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2021-02-26 Korean
투자판단관련주요경영사항(COVID-19 치료제 Lenzilumab의 식약처 가교임상시험 계획 (IND) 승인 신청)
Legal Proceedings Report
2021-01-25 Korean
주요사항보고서(전환사채권발행결정)
Share Issue/Capital Change
2021-01-18 Korean
증권발행결과(자율공시)
Share Issue/Capital Change
2021-01-18 Korean